Tag: MDR

Blue Horseshoe Stocks: BRAV Recap & More

Bravada International, Ltd. BRAV

We tagged BRAV in Friday morning’s premarket report after noticing increased volume and price action in the stock on our routine morning scan. It responded with one heck of a strong intraday performance, allowing traders a shot at a double bagger on the day.

BRAV traded up from its early morning low of .00128 to hit a high of .0028 shortly after 12:40pm, which was good for a 118% rip, and it came on 20X the 30-day average volume.

Deere & Co. DE – Friday Recap

We wanted to briefly mention our DE options idea for Friday’s session, the DE Weekly $118-121 Call.
 We normally include the exact gains made by our options calls, but are unable to on this play due to a technical difficulty, so we apologize for that.

That being said, DE ran from 119.00 to 122.24 on the day, and the potential for multi-bag gains in every single one of our highlighted contracts certainly were there for the taking.

FerroGlobe PLC (GSM)

A stock that’s hitting our scanner today is GSM, which recently came down to touch the lowest prices it had seen in eight months, and has been rebounding in anticipation of Q1 Earnings, which were released yesterday and are untraded-upon.

Additionally, the RSI on the GSM chart is about to break the 50-line, while the MACD has just undergone a bullish cross. A return to PPS levels of just three months ago would produce gains of 30% or more from current pricing. We’ll place GSM on watch over the next few sessions and will be interested to see how the activity plays out.

GlycoMimetics, Inc. GLYC – Recap

We were tracking GLYC late last week, and it turned out to be a rousing success. The stock saw a low of 7.21 on Thursday following our premarket alert, and on Friday it hit 14.64, for a two-session swing of 103% which is fantastic for a stock in this price range.

Extended Watchlist:
BIOC, CMCM, OCLR, GNC, MDR, SPHS,

Blue Horseshoe Stocks: ONCY Recap & More

Oncolytics Biotech, Inc. ONCY

ONCY emerged from our extended watchlist and stole the show yesterday with an exceptional intraday run. The stock saw an early morning low of .80 then proceeded to bull its way upward for the remainder of the session, breaking through the 200DMA (.92) and setting its daily high of 1.10 inside of the last hour of trading.

The spike was good for gains of up to 37% on the day, and ONCY held a vast majority of those gains, closing at 1.07. We were extremely pleased with our timing in flagging this play when we did; the strong performance came on more than 12x the 3-month average number of shares traded, setting a new 52-week high for volume in the process.

With the kind of breakout momentum we saw build up in ONCY yesterday, we’re going to continue to reserve a spot for it on our watchlist, provided the stock can maintain support at or above the .85-.87 area on any pullbacks. It’s gapping up in the premarket this morning, so there’s a reasonable chance of some early profit-taking today.

ONCY is currently being given a 88% Overall “Buy” Opinion Rating at BARCHART.COM

Ohr Pharmaceutical, Inc. OHRP

We also wanted to make a note of another of our stated items of interest which made a nice move right off the bat yesterday. OHRP came off of our extended watchlist to trade in a range from 8.55-10.58, a 24% intraday increase.

Volume came in at more 16x the 3-month average for the session. The stock held more than half of its daily advances into the close (9.78), and is gapping up slightly in premarket trading this morning. The stock will receive our continued attention in the event that it can hold support above 9.50.
–

Biocept, Inc. BIOC

BIOC began appearing in our reports for the first time back on February 17th via our extended watchlist. Subsequent to that point, we witnessed the stock spike in a big way from a low of 1.35 up to a high of 4.91 just seven sessions later on February 25th; an initial run equal to an increase of 264%

After consolidating off of that high the stock found support at 2.73 on Friday before beginning to rebound. Yesterday brought a continuation of that recovery as BIOC found its way back to 3.94, which marks a 44% swing.

Extended Watchlist:
 MDR, FNJN, AMCO